JL Kendall, JM Springer - Current Rheumatology Reports, 2020 - Springer
Abstract Purpose of Review We aim to describe the pathophysiology, clinical findings, diagnosis, and treatment of deficiency of adenosine deaminase 2 (DADA2). Recent Findings …
I Maccora, V Maniscalco, S Campani, S Carrera… - Orphanet Journal of …, 2023 - Springer
Introduction Deficiency of adenosine deaminase 2 (DADA2) is a rare monogenic autoinflammatory disease, whose clinical phenotype was expanded since the first cases …
G Li, X Han, Y Wu, W Wang, H Tang, M Lu… - Journal of Clinical …, 2023 - Springer
Purpose Deficiency of adenosine deaminase 2 (DADA2), an autosomal recessive autoinflammatory disorder caused by biallelic loss-of-function variants in adenosine …
F Alabbas, T Alanzi, A Alrasheed, M Essa… - Journal of Clinical …, 2023 - Springer
Abstract Adenosine deaminase 2 deficiency (DADA2), a rare and potentially fatal systemic autoinflammatory disease, is characterized by low or lack of ADA2 activity due to ADA2 …
B Balažiová, G Hrčková, V Dobšinská… - Vnitřní …, 2024 - casopisvnitrnilekarstvi.cz
Deficiency of adenosine deaminase type 2 (DADA2) is a genetically determined multisystem autoinflammatory disease first described in 2014. It results from pathogenic variants in the …